Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,935 USD | -8,49% | -21,83% | +5,35% |
Vakgebied
Aantal werknemers: 181
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cellular Immunotherapies
100,0
%
| 96 | 100,0 % | 64 | 100,0 % | -34,03% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 96 | 100,0 % | 64 | 100,0 % | -34,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
J. Wolchko
FOU | Founder | 53 | 27-04-07 |
Edward Dulac
DFI | Director of Finance/CFO | 49 | 17-08-20 |
Chairman | 75 | 01-11-11 | |
Wen Bo Wang
CTO | Chief Tech/Sci/R&D Officer | - | 08-10-18 |
Bahram Valamehr
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-08-18 |
Jerome C. Bressi
LAW | General Counsel | - | 01-12-18 |
Cindy Tahl
LAW | General Counsel | 51 | 01-01-09 |
Jim Beitel
PRN | Corporate Officer/Principal | - | 14-09-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Epstein
BRD | Director/Board Member | 69 | 17-03-14 |
Robert Hershberg
BRD | Director/Board Member | 61 | 01-05-20 |
Tim Coughlin
BRD | Director/Board Member | 57 | 01-08-13 |
Chairman | 75 | 01-11-11 | |
John Mendlein
FOU | Founder | 64 | 27-04-07 |
J. Wolchko
FOU | Founder | 53 | 27-04-07 |
Michael Lee
BRD | Director/Board Member | 45 | 31-07-18 |
Karin Jooss
BRD | Director/Board Member | 59 | 14-03-19 |
Shefali Agarwal
BRD | Director/Board Member | 50 | 15-07-19 |
Yuan Xu
BRD | Director/Board Member | 56 | 03-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 113 172 530 | 111 508 920 ( 98,53 %) | 0 | 98,53 % |
Aandeel B | 0 | 2 761 108 | 0 | 0 |
Bedrijfsgegevens
Fate Therapeutics, Inc.
12278 Scripps Summit Drive
92131, San Diego
+858 875 1800
http://www.fatetherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,35% | 489 mln. | |
-3,16% | 104 mld. | |
+0,85% | 97,42 mld. | |
+0,79% | 22,2 mld. | |
-17,86% | 21,23 mld. | |
-11,11% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-16,10% | 15,06 mld. | |
+3,64% | 13,98 mld. | |
+33,49% | 11,66 mld. |
- Beurs
- Aandelen
- Koers FATE
- Onderneming Fate Therapeutics, Inc.